18
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Reduced Dose Imatinib Mesylate Therapy for Chronic Myeloid Leukemia

&
Pages 2363-2364 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Edgar Faber, Jitka Naušová, Marie Jarošová, Merrill J. Egorin, Milena Holzerová, Šárka Rožmanová, Ivana Marešová, Vladimír Divoký & Karel Indrák. (2006) Intermittent dosage of imatinib mesylate in CML patients with a history of significant hematologic toxicity after standard dosing. Leukemia & Lymphoma 47:6, pages 1082-1090.
Read now

Articles from other publishers (1)

Faouzi Djebbari, Nicola Stoner & Verna Teresa Lavender. (2018) A systematic review of non-standard dosing of oral anticancer therapies. BMC Cancer 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.